BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21923245)

  • 1. Invasion of the corticotrophs.
    Mayberg MR
    J Neurosurg; 2012 Feb; 116(2):269-71; discussion 270-1. PubMed ID: 21923245
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospective evaluation of the characteristics and incidence of adenoma-associated dural invasion in Cushing disease.
    Lonser RR; Ksendzovsky A; Wind JJ; Vortmeyer AO; Oldfield EH
    J Neurosurg; 2012 Feb; 116(2):272-9. PubMed ID: 21923247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cushing's disease and dural invasion.
    Hueng DY; Ma HI; Chen CM
    J Neurosurg; 2012 Jul; 117(1):189-90; author reply 190-1. PubMed ID: 22577750
    [No Abstract]   [Full Text] [Related]  

  • 4. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
    Meij BP; Lopes MB; Ellegala DB; Alden TD; Laws ER
    J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silent or Subclinical Corticotroph Pituitary Macroadenoma Transforming Into Cushing Disease: 11-Year Follow-up.
    Melcescu E; Gannon AW; Parent AD; Fratkin JF; Nicholas WC; Koch CA; Galhom A
    Neurosurgery; 2013 Jan; 72(1):E144-6. PubMed ID: 23037824
    [No Abstract]   [Full Text] [Related]  

  • 6. Concerning the article "Cushing's disease associated with both pituitary microadenoma and corticotroph hyperplasia".
    Saeger W
    Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):68. PubMed ID: 20127571
    [No Abstract]   [Full Text] [Related]  

  • 7. Prospective evaluation of transsphenoidal pituitary surgery in 108 patients with Cushing's disease.
    Rollin G; Ferreira NP; Czepielewski MA
    Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1355-61. PubMed ID: 18209874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of surgical treatment of 200 children with Cushing's disease.
    Lonser RR; Wind JJ; Nieman LK; Weil RJ; DeVroom HL; Oldfield EH
    J Clin Endocrinol Metab; 2013 Mar; 98(3):892-901. PubMed ID: 23372173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical type II silent corticotrophic adenoma developing into Cushing's disease upon second recurrence.
    Psaras T; Honegger J; Buslei R; Saeger W; Klein D; Capper D; Meyermann R; Mittelbronn M
    Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):610-5. PubMed ID: 17943697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transsphenoidal surgery for Cushing's disease: a review of success rates, remission predictors, management of failed surgery, and Nelson's Syndrome.
    Kelly DF
    Neurosurg Focus; 2007; 23(3):E5. PubMed ID: 17961026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silent corticotroph adenoma.
    Rajesh A
    Neurosurgery; 2013 Jul; 73(1):E191-2. PubMed ID: 23615102
    [No Abstract]   [Full Text] [Related]  

  • 12. Ectopic Adrenocorticotropic Hormone-Secreting Pituitary Adenomas: An Underestimated Entity.
    Knappe UJ; Jaspers C; Buschsieweke D; Reinbold WD; Alomari A; Saeger W; Ehlenz K; Mann WA; Kann PH; Feldkamp J
    Neurosurgery; 2017 Apr; 80(4):525-533. PubMed ID: 27352274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approach to the postoperative patient with Cushing's disease.
    Rutkowski MJ; Breshears JD; Kunwar S; Aghi MK; Blevins LS
    Pituitary; 2015 Apr; 18(2):232-7. PubMed ID: 25702104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes and management of patients with Cushing's disease without pathological confirmation of tumor resection after transsphenoidal surgery.
    Pouratian N; Prevedello DM; Jagannathan J; Lopes MB; Vance ML; Laws ER
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3383-8. PubMed ID: 17595252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cushing's disease due to double pituitary ACTH-secreting adenomas: the first case report.
    Andrioli M; Pecori Giraldi F; Losa M; Terreni M; Invitti C; Cavagnini F
    Endocr J; 2010; 57(9):833-7. PubMed ID: 20595779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In reply.
    Koch CA
    Neurosurgery; 2013 Jul; 73(1):E192. PubMed ID: 23615112
    [No Abstract]   [Full Text] [Related]  

  • 17. POSTSURGICAL RECURRENT CUSHING DISEASE: CLINICAL BENEFIT OF EARLY INTERVENTION IN PATIENTS WITH NORMAL URINARY FREE CORTISOL.
    Carroll TB; Javorsky BR; Findling JW
    Endocr Pract; 2016 Oct; 22(10):1216-1223. PubMed ID: 27409817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status on histological classification in Cushing's disease.
    Syro LV; Rotondo F; Cusimano MD; Di Ieva A; Horvath E; Restrepo LM; Wong M; Killinger DW; Smyth H; Kovacs K
    Pituitary; 2015 Apr; 18(2):217-24. PubMed ID: 25501318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for ACTH-dependent hypercortisolism in patients with pituitary incidentaloma.
    Torpy DJ
    Eur J Endocrinol; 2015 Apr; 172(4):C1-4. PubMed ID: 25609777
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety of transsphenoidal microsurgical approach in patients with an ACTH-secreting pituitary adenoma.
    Donofrio CA; Losa M; Gemma M; Giudice L; Barzaghi LR; Mortini P
    Endocrine; 2017 Nov; 58(2):303-311. PubMed ID: 28005257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.